UK teams up with Singapore on healthtech regulation
A partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly.
Newsletters and Deep Dive digital magazine
A partnership between medicines regulators in the UK and Singapore could allow patients in both countries to access new medical advances more quickly.
Flow Neuroscience has secured FDA approval for FL-100, the first at-home brain stimulation device for major depressive disorder.
This hidden data crisis is the fundamental barrier to scaling AI in the life sciences sector.
Hims & Hers has launched its direct-to-consumer weight-loss therapy channel in the UK, offering Wegovy, Mounjaro, and OTC option Orlos.
AI-powered integrated platforms offer an elemental shift in the way that clinical trials are conducted.
Editor's Picks
Newsletters and Deep Dive
digital magazine